+关注
JoshuaS
暂无个人介绍
IP属地:北京
28
关注
0
粉丝
3
主题
0
勋章
主贴
热门
JoshuaS
2021-08-26
$海吉亚医疗(06078)$
为啥一直跌,财报好也不管用吗
JoshuaS
2021-06-04
这股价对得起人家的投资吗?
乐享互动继加入MSCI指数后 又获巨头贝莱德和道富集团投资
JoshuaS
2021-02-19
$海吉亚医疗(06078)$
什么情况?
JoshuaS
2020-12-07
$嘉和生物-B(06998)$
多涨点吧哎
JoshuaS
2020-12-04
$嘉和生物-B(06998)$
一切没量的上涨都是耍流氓
JoshuaS
2020-12-01
$嘉和生物-B(06998)$
38个交易日里,25个收红下跌,剩下13个收绿的交易日里,6个横盘微动,真正实现3%以上涨幅的只有3个交易日,嘉和生物真是一支优秀的股票!
JoshuaS
2020-11-15
$嘉和生物-B(06998)$
涨涨涨
JoshuaS
2020-11-13
$嘉和生物-B(06998)$
硬一次,软三天
JoshuaS
2020-11-07
$阿里巴巴-SW(09988)$
周一请紧跟美股步伐
JoshuaS
2020-11-06
$嘉和生物-B(06998)$
今天加油💪
JoshuaS
2020-11-05
$嘉和生物-B(06998)$
大哥,学学药明巨诺今天的涨幅吧
JoshuaS
2020-11-02
意料之内
先声药业(02096.HK):行业长跑型选手,医药"组合拳"构建护城河
JoshuaS
2020-11-02
$嘉和生物-B(06998)$
这个铁憨憨啊,天天就知道跌。
JoshuaS
2020-11-01
$嘉和生物-B(06998)$
周一涨涨吧
JoshuaS
2020-10-31
$乐享互动(06988)$
竟然还在涨
JoshuaS
2020-10-30
$嘉和生物-B(06998)$
大哥,公司出啥事儿了
JoshuaS
2020-10-29
$嘉和生物-B(06998)$
没量呀
JoshuaS
2020-10-28
$嘉和生物-B(06998)$
kao
JoshuaS
2020-10-27
$嘉和生物-B(06998)$
这是彻底没心跳了?
JoshuaS
2020-10-26
$海吉亚医疗(06078)$
看好这支
去老虎APP查看更多动态
{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":3468821296231434,"uuid":"3468821296231434","gmtCreate":1508783334802,"gmtModify":1603865070491,"name":"JoshuaS","pinyin":"joshuas","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/a71fb2b3a9de6819c3c7b1feac5d0ef2","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":28,"tweetSize":54,"questionSize":0,"limitLevel":900,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":3,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-4","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"明星虎友","description":"加入老虎社区2000天","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.04.17","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.22","exceedPercentage":"93.51%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.73%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.15%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},"individualDisplayBadges":null,"crmLevel":3,"crmLevelSwitch":0,"location":"北京","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":810342327,"gmtCreate":1629947588969,"gmtModify":1629947588969,"author":{"id":"3468821296231434","authorId":"3468821296231434","name":"JoshuaS","avatar":"https://static.tigerbbs.com/a71fb2b3a9de6819c3c7b1feac5d0ef2","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/06078\">$海吉亚医疗(06078)$</a>为啥一直跌,财报好也不管用吗","listText":"<a href=\"https://laohu8.com/S/06078\">$海吉亚医疗(06078)$</a>为啥一直跌,财报好也不管用吗","text":"$海吉亚医疗(06078)$为啥一直跌,财报好也不管用吗","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/810342327","isVote":1,"tweetType":1,"viewCount":2997,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":116896470,"gmtCreate":1622785937590,"gmtModify":1622785937590,"author":{"id":"3468821296231434","authorId":"3468821296231434","name":"JoshuaS","avatar":"https://static.tigerbbs.com/a71fb2b3a9de6819c3c7b1feac5d0ef2","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"这股价对得起人家的投资吗?","listText":"这股价对得起人家的投资吗?","text":"这股价对得起人家的投资吗?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/116896470","repostId":"2140471186","repostType":2,"repost":{"id":"2140471186","pubTimestamp":1622777314,"share":"https://www.laohu8.com/m/news/2140471186?lang=&edition=full","pubTime":"2021-06-04 11:28","market":"sh","language":"zh","title":"乐享互动继加入MSCI指数后 又获巨头贝莱德和道富集团投资","url":"https://stock-news.laohu8.com/highlight/detail?id=2140471186","media":"智通财经","summary":"继5月27日被正式纳入MSCI中国小型股指数后,乐享互动(06988)又获两家国际顶级金融巨头贝莱德和道富集团投资。资料显示,贝莱德集团披露其持有乐享互动256.9万股,占已发行股份的0.12%;美国 ...","content":"<html><body><div>\n<p> 继5月27日被正式纳入MSCI中国小型股指数后,<a href=\"https://laohu8.com/S/06988\">乐享互动</a>(06988)又获两家国际顶级金融巨头<a href=\"https://laohu8.com/S/BLK\">贝莱德</a>和道富集团投资。资料显示,贝莱德集团披露其持有乐享互动256.9万股,占已发行股份的0.12%;美国道富集团披露其持有乐享互动62.9万股,占已发行股份的0.03%。</p>\n<p><strong>关注<a href=\"https://laohu8.com/S/300033\">同花顺</a>财经(ths518),获取更多机会</strong></p>\n<span></span>\n<div><span>责任编辑:lg</span></div>\n</div></body></html>","source":"tonghuashun","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>乐享互动继加入MSCI指数后 又获巨头贝莱德和道富集团投资</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n乐享互动继加入MSCI指数后 又获巨头贝莱德和道富集团投资\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-04 11:28 北京时间 <a href=http://stock.10jqka.com.cn/hks/20210604/c629952344.shtml><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>继5月27日被正式纳入MSCI中国小型股指数后,乐享互动(06988)又获两家国际顶级金融巨头贝莱德和道富集团投资。资料显示,贝莱德集团披露其持有乐享互动256.9万股,占已发行股份的0.12%;美国道富集团披露其持有乐享互动62.9万股,占已发行股份的0.03%。\n关注同花顺财经(ths518),获取更多机会\n\n责任编辑:lg</p>\n\n<a href=\"http://stock.10jqka.com.cn/hks/20210604/c629952344.shtml\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/88496460f2979fb6bfc7007e44d1e10a","relate_stocks":{"06988":"乐享集团","BLK":"贝莱德"},"source_url":"http://stock.10jqka.com.cn/hks/20210604/c629952344.shtml","is_english":false,"share_image_url":"https://static.laohu8.com/f0343184bd9b9c963ed02b302442e2b8","article_id":"2140471186","content_text":"继5月27日被正式纳入MSCI中国小型股指数后,乐享互动(06988)又获两家国际顶级金融巨头贝莱德和道富集团投资。资料显示,贝莱德集团披露其持有乐享互动256.9万股,占已发行股份的0.12%;美国道富集团披露其持有乐享互动62.9万股,占已发行股份的0.03%。\n关注同花顺财经(ths518),获取更多机会\n\n责任编辑:lg","news_type":1},"isVote":1,"tweetType":1,"viewCount":793,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":387994484,"gmtCreate":1613706584948,"gmtModify":1613706584948,"author":{"id":"3468821296231434","authorId":"3468821296231434","name":"JoshuaS","avatar":"https://static.tigerbbs.com/a71fb2b3a9de6819c3c7b1feac5d0ef2","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/06078\">$海吉亚医疗(06078)$</a>什么情况?","listText":"<a href=\"https://laohu8.com/S/06078\">$海吉亚医疗(06078)$</a>什么情况?","text":"$海吉亚医疗(06078)$什么情况?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/387994484","isVote":1,"tweetType":1,"viewCount":1283,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":392906150,"gmtCreate":1607348587070,"gmtModify":1703847269414,"author":{"id":"3468821296231434","authorId":"3468821296231434","name":"JoshuaS","avatar":"https://static.tigerbbs.com/a71fb2b3a9de6819c3c7b1feac5d0ef2","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/06998\">$嘉和生物-B(06998)$</a>多涨点吧哎","listText":"<a href=\"https://laohu8.com/S/06998\">$嘉和生物-B(06998)$</a>多涨点吧哎","text":"$嘉和生物-B(06998)$多涨点吧哎","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/392906150","isVote":1,"tweetType":1,"viewCount":807,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":396169740,"gmtCreate":1607069323180,"gmtModify":1703846227773,"author":{"id":"3468821296231434","authorId":"3468821296231434","name":"JoshuaS","avatar":"https://static.tigerbbs.com/a71fb2b3a9de6819c3c7b1feac5d0ef2","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/06998\">$嘉和生物-B(06998)$</a>一切没量的上涨都是耍流氓","listText":"<a href=\"https://laohu8.com/S/06998\">$嘉和生物-B(06998)$</a>一切没量的上涨都是耍流氓","text":"$嘉和生物-B(06998)$一切没量的上涨都是耍流氓","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/396169740","isVote":1,"tweetType":1,"viewCount":1303,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":398038113,"gmtCreate":1606788512032,"gmtModify":1703844421830,"author":{"id":"3468821296231434","authorId":"3468821296231434","name":"JoshuaS","avatar":"https://static.tigerbbs.com/a71fb2b3a9de6819c3c7b1feac5d0ef2","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/06998\">$嘉和生物-B(06998)$</a>38个交易日里,25个收红下跌,剩下13个收绿的交易日里,6个横盘微动,真正实现3%以上涨幅的只有3个交易日,嘉和生物真是一支优秀的股票!","listText":"<a href=\"https://laohu8.com/S/06998\">$嘉和生物-B(06998)$</a>38个交易日里,25个收红下跌,剩下13个收绿的交易日里,6个横盘微动,真正实现3%以上涨幅的只有3个交易日,嘉和生物真是一支优秀的股票!","text":"$嘉和生物-B(06998)$38个交易日里,25个收红下跌,剩下13个收绿的交易日里,6个横盘微动,真正实现3%以上涨幅的只有3个交易日,嘉和生物真是一支优秀的股票!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":13,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/398038113","isVote":1,"tweetType":1,"viewCount":1351,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":307977128,"gmtCreate":1605439594164,"gmtModify":1703837718730,"author":{"id":"3468821296231434","authorId":"3468821296231434","name":"JoshuaS","avatar":"https://static.tigerbbs.com/a71fb2b3a9de6819c3c7b1feac5d0ef2","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/06998\">$嘉和生物-B(06998)$</a>涨涨涨","listText":"<a href=\"https://laohu8.com/S/06998\">$嘉和生物-B(06998)$</a>涨涨涨","text":"$嘉和生物-B(06998)$涨涨涨","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/307977128","isVote":1,"tweetType":1,"viewCount":711,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":304673686,"gmtCreate":1605231586845,"gmtModify":1703836894188,"author":{"id":"3468821296231434","authorId":"3468821296231434","name":"JoshuaS","avatar":"https://static.tigerbbs.com/a71fb2b3a9de6819c3c7b1feac5d0ef2","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/06998\">$嘉和生物-B(06998)$</a>硬一次,软三天","listText":"<a href=\"https://laohu8.com/S/06998\">$嘉和生物-B(06998)$</a>硬一次,软三天","text":"$嘉和生物-B(06998)$硬一次,软三天","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/304673686","isVote":1,"tweetType":1,"viewCount":1011,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":302749131,"gmtCreate":1604758798823,"gmtModify":1703834711700,"author":{"id":"3468821296231434","authorId":"3468821296231434","name":"JoshuaS","avatar":"https://static.tigerbbs.com/a71fb2b3a9de6819c3c7b1feac5d0ef2","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/09988\">$阿里巴巴-SW(09988)$</a>周一请紧跟美股步伐","listText":"<a href=\"https://laohu8.com/S/09988\">$阿里巴巴-SW(09988)$</a>周一请紧跟美股步伐","text":"$阿里巴巴-SW(09988)$周一请紧跟美股步伐","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/302749131","isVote":1,"tweetType":1,"viewCount":826,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":302681939,"gmtCreate":1604621235921,"gmtModify":1703834123559,"author":{"id":"3468821296231434","authorId":"3468821296231434","name":"JoshuaS","avatar":"https://static.tigerbbs.com/a71fb2b3a9de6819c3c7b1feac5d0ef2","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/06998\">$嘉和生物-B(06998)$</a>今天加油💪","listText":"<a href=\"https://laohu8.com/S/06998\">$嘉和生物-B(06998)$</a>今天加油💪","text":"$嘉和生物-B(06998)$今天加油💪","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/302681939","isVote":1,"tweetType":1,"viewCount":893,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":302371856,"gmtCreate":1604566064875,"gmtModify":1703833781393,"author":{"id":"3468821296231434","authorId":"3468821296231434","name":"JoshuaS","avatar":"https://static.tigerbbs.com/a71fb2b3a9de6819c3c7b1feac5d0ef2","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/06998\">$嘉和生物-B(06998)$</a>大哥,学学药明巨诺今天的涨幅吧","listText":"<a href=\"https://laohu8.com/S/06998\">$嘉和生物-B(06998)$</a>大哥,学学药明巨诺今天的涨幅吧","text":"$嘉和生物-B(06998)$大哥,学学药明巨诺今天的涨幅吧","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/302371856","isVote":1,"tweetType":1,"viewCount":797,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":306334729,"gmtCreate":1604283750761,"gmtModify":1703832336252,"author":{"id":"3468821296231434","authorId":"3468821296231434","name":"JoshuaS","avatar":"https://static.tigerbbs.com/a71fb2b3a9de6819c3c7b1feac5d0ef2","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"意料之内","listText":"意料之内","text":"意料之内","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/306334729","repostId":"2078500372","repostType":2,"repost":{"id":"2078500372","pubTimestamp":1603774470,"share":"https://www.laohu8.com/m/news/2078500372?lang=&edition=full","pubTime":"2020-10-27 12:54","market":"hk","language":"zh","title":"先声药业(02096.HK):行业长跑型选手,医药\"组合拳\"构建护城河","url":"https://stock-news.laohu8.com/highlight/detail?id=2078500372","media":"格隆汇","summary":"作为一家快速转型为创新和研发驱动的制药公司,先声药业目前主要专注三大领域,包括肿瘤疾病(包括细胞治疗领域)、中枢神经系统疾病、自身免疫疾病。","content":"<html><body><p><span>今日<a href=\"https://laohu8.com/S/02096\">先声药业</a>(02096.HK)登陆港交所,</span><span>截至</span><span>发稿时为止股价表现不佳,在市场上引发了一定的争议,而在这之前,公司公开发售获得了589.47倍认购,在市场如此追捧的背景下,先声药业股价下跌究竟是何原因?又该如何看待这家公司的长期价值呢?</span></p><p>初步分析来看,我们认为这与近期一系列公司密集在港股上市,尤其是<a href=\"https://laohu8.com/S/06688\">蚂蚁集团</a>上市消息对港股打新市场环境带来的影响有较大关系。此前市场曾一度传出蚂蚁集团上市暂缓,而彼时正值先声药业的招股期,这在一定程度上刺激了先声药业的招股表现,而随着蚂蚁集团上市得到确认,可能引发的抽水效应预期之下,继而又给上市的新股带来了一定压力。在此背景下,先声药业未有预期表现也就不难理解。</p><p>而此次先声药业获得了高瓴资本的加持,这也是进一步刺激投资者认购的重要因素,也难怪会有人因暗盘表现吐槽高瓴资本\"翻车\"。不过私以为,正如高瓴资本的创始人所践行的投资标准——做时间的朋友,仅为先声药业短期的价格波动而为之\"酸柠檬\",实在不可取,不妨具体来探讨为何在高领资本眼中先声药业是一家值得长期下注的企业。</p><blockquote><b><font color=\"#ff0000\">1、昔日国内首个美股上市药企,资本市场二聚首</font></b></blockquote><p>此次港股上市并非先声药业首次亮相资本市场,早在2007年,该公司曾成功登陆纽交所,并成为当时国内第一家在纽交所上市的化学生物药企。上市初期先声药业市值还一度刷新了亚洲化学生物药企的IPO记录,不过后来,由于公司长期在美股市场面临低估局面,公司最终选择在2013年完成私有化从纽交所退市。</p><p>从当时退市的背景来看,彼时公司正处于黄金发展期,由于面临强研发投入在一定程度上影响了公司短期盈利,导致财务报表并不好看,而资本市场向来也多是对业绩唯马是瞻,投资者给出的估值不高,再融资难度较大,维持上市地位也将需要一定的成本支出,综合一系列因素考量下,私有化退市成为彼时先声药业面临的更为明智的选择。</p><p>随着近年来港交所积极改革,医药企业面临的资本市场环境已经与当年的美股市场不可同日而语,其中最具看点的便是未盈利的B字头股票走出了大牛行情。除了资本市场的变化,先声药业经过多年的沉淀实际上也早已经脱胎换骨,公司连续多年位居“中国创新力医药企业十强”和“中国制药工业百强”,行业地位进一步提升,研发成果得到市场验证。在此背景下,二次上市再融资,寻求进一步做大做强成了可能。</p><p><img src=\"https://img3.gelonghui.com/62c0c-fb3a913f-859a-4887-8a3e-96ee060b6a17.png\"/></p><p>作为一家快速转型为创新和研发驱动的制药公司,先声药业目前主要专注三大领域,包括肿瘤疾病(包括细胞治疗领域)、中枢神经系统疾病、自身免疫疾病。根据弗若斯特沙利文的资料,按药品销售收入计,上述三大治疗领域2019年合计占中国药品市场的24.7%,且2015年到2019年的增长速度快于整体<a href=\"https://laohu8.com/S/600056\">中国医药</a>行业增速,预计这一趋势在未来几年将延续。由上不难看出公司在医药行业选择的赛道具有非常乐观的前景,那么对于公司本身而言,其机会和竞争力又体现在何处?</p><blockquote><b><font color=\"#ff0000\">2、左手\"现金牛\",右手\"冲天炮\"</font></b></blockquote><p>相较于B字尾未盈利的生物医药企业,先声药业与其最大的不同之处在于公司既有良好的现金牛业务能够在一定程度上支撑公司日常运营及强研发投入,同时又有具备想象空间的在研创新药产品,为未来的发展增添潜在<a href=\"https://laohu8.com/S/600405\">动力源</a>,可被视作将来能够带领公司业绩一飞冲天的\"冲天炮\"。</p><p>从\"现金牛\"来看,目前公司共销售10款产品,其中7种仿制药、2种一类创新药及1种改良型新药,这些药品在相应的细分领域占有领先的市场地位,数据显示,10款主要产品的销售额占2019财年总收入的81.9%。其中占比最多的产品包括恩度、必存和艾得辛,三者2019财年销售额合计占比总收入超5成。</p><p><img src=\"https://img3.gelonghui.com/20ef8-05ae2c1d-5d4b-4954-8c1d-3f5e35850610.png\"/></p><p>另外按照此前提到的公司具体聚焦的肿瘤疾病、中枢神经系统疾病和自身免疫疾病三大领域来看,这三大领域的收入2019财年占比达到65.9%,可以说是公司的基本盘所在。</p><p>结合财报来数据来看,先声药业营收、净利润近年来保持高增长态势,2017-2019营收年复合增长率达到近20%,净利润年复合增长率达到70%。此外体现在盈利指标方面,2017-2019年,先声药业的毛利率分别为84.8%、82.9%、82.4%;ROE分别为21.3%、43.9%、65.9%,毛利率持续维持高位姿态,盈利能力不断强化。</p><p><img src=\"https://img3.gelonghui.com/2131b-8d2ecd73-dd61-41be-a63b-4fbaf2ed3032.png\"/></p><p>可见公司所战略性布局的三大领域以及多元化的产品,得到了市场认可,保持了稳定的销售态势,并成为保障公司业绩稳健表现的重要根基。而基于此,相较于很多处于研发阶段但并未有正式产品上市的未盈利企业,先声医药具备了一定的经营安全垫,而这也将体现在投资上,增厚了投资者的安全边际。</p><p>而再来看为未来赋予想象空间的在研药物方面,根据招股书,目前先声药业拥有近50个处于不同开发阶段的在研创新药产品,包括小分子药物、大分子药物和CART细胞治疗,其中近10种已取得新药临床批文或处于临床阶段,预计未来几年将就17种仿制药及生物类似药在研产品,提交或取得仿制药注册申请或进口药品注册申请。可以说其构筑了具有前瞻性且市场潜力巨大的系统研发管线。</p><p><img src=\"https://img3.gelonghui.com/b5d23-adc9ad89-b038-4b58-9a6d-9b0e2ee95370.png\"/></p><p>而以市场关注最多的新上市或临近上市的重磅产品为例,公司于今年8月份推出的恩瑞舒(阿巴西普注射液)以及先必新(依达拉奉右莰醇注射用浓溶液),均通过国家医保药品大病谈判资格审查,以获纳入国家医保药品目录。</p><p>其中阿巴西普作为全球类风湿关节炎领域第一个也是唯一一个被批准的T细胞选择性共刺激免疫调节剂,恩瑞舒针对ACPA阳性患者疗效更强,安全性更好。2019年,阿巴西普全球销售额接近30亿美元,此次进入中国大陆市场后,将惠及国内600万类风关患者,市场前景十分可观。</p><p>另外,国家1类新药先必新(依达拉奉右莰醇注射用浓溶液)其作为全球脑卒中治疗领域近5年来唯一获批上市销售的创新药,其可显著降低急性缺血性脑卒中(AIS)引发的脑神经损伤,并将现有治疗时间窗从24小时延长至48小时。而根据《中国脑卒中防治报告》,我国每12秒就有一人发生脑卒中,每21秒就有一人死于脑卒中,全国每年死于脑卒中的患者高达190多万。先必新的上市,为卒中患者带来新的选择,也有望进一步打开市场格局。</p><p>最后再来看即将上市的重磅产品KN035 (Envafolimab),该产品尽管只是合作产品,先声药业主要负责该产品在中国大陆的独家商业推广,并以此收取推广服务费。不过作为全球首个上市的通过皮下注射给药的PD1/PD-L1抗体。KN035在安全性、便利性、依从性等方面和已上市的同类药物相比,具有显著的差异化优势,目前其已获得了美国FDA的晚期胆道癌孤儿药资格认定,市场前景也相当乐观。</p><p>综上不难看出,先声药业不论是在自身的研发领域,还是优势互补合作方面都展现了实力雄厚的一面,透过多维度布局不仅拓宽了市场机会,同时也打开了更多向上发展空间。</p><blockquote><b><font color=\"#ff0000\">3、短期承压不改长期趋势,两大亮点支撑价值创造</font></b></blockquote><p>当前受短期市场环境影响,先声药业上市表现面临一定压力,不过随着巨无霸蚂蚁集团的落地,市场恢复常态,在蚂蚁金服的吸金效应之下,更多市场资金的涌入将有助于提升整体市场流动性,带动基本面优质的低估值企业迎来修复。而从长远视角而言,我们总结了两大亮点,认为将是公司投资价值的重要体现所在,也是支撑公司未来长期估值表现的核心要素。</p><p>其一,前瞻性的市场眼光以及持续提升的研发能力</p><p>不论是早在2015年就上市了国内首个肿瘤生物药物开创市场先河,还是今年两大重磅药品一经面试即入围医保审查名单,这些均有力体现了先声药业长期发展过程中积淀的超强市场洞察力。公司扎根医药行业中更具备前景和增长机会的三大领域,在优势赛道上抢跑,成长性也将得到更进一步的体现。</p><p>此外研发上,过去公司业务主要以仿制药为主,而随着行业仿制药业务加速洗牌,公司大力推进创新药研发,在研发能力上有了长足的进步。</p><p>招股资料显示,先声药业在江苏省南京市、上海市和美国波士顿拥有三个研发中心,为创新药物国家重点实验室。人员配备上,公司研发部门共有全职员工756人,其中331人拥有硕士学历,116人拥有博士学历。而在研发投入方面,其占营收比节节攀升,19年达到14.2%。</p><p>其二,商业化水平领先,加速资源整合,优势互补下打开成长空间</p><p>作为老牌药企,先声药业在行业内有着丰富的资源积累,商业化水平处于行业领先水准。数据显示,截止2020年6月30日,公司拥有超过2800名销售及营销人员,遍布中国31个省、市级自治区,覆盖全国约2100家三级医院,约17000家其他医院、医疗机构,以及超过200家大型全国性或区域性连锁药店。优质的资源网络及市场影响力为后续公司在研产品的上市推广带来了强劲支撑,而借助此公司还打开了新的业务窗口。</p><p>此前上面提到的重磅产品KN035 (Envafolimab)即是先声药业凭借其强大的商业化能力,从而获得该药品国内独家商业推广,并借此取得推广收入。从长远来看,借助与优质资源的合作,在早期研发、临床开发、商业化推广上各方实现优势互补,这也将有助于进一步为公司创造新的业务价值点,在资源整合之中打开更大的市场机会。</p><blockquote><b><font color=\"#ff0000\">4、结语</font></b></blockquote><p>此前<a href=\"https://laohu8.com/S/601377\">兴业证券</a>观点指出,国内企业的研发类型从单纯的模仿/改进到快速跟进(Fast-follow)甚至逐步追求 First-in-class。研发管线逐步成为投资者估值和决定企业股价走势的重要考量因素。结合先声药业的发展路径来看,其不断加大研发投入,打造了多元化创新产品组合,这些布局不仅为未来的业绩增长带来了想象空间,同时也将有力支撑公司未来股价表现。</p><p>也正是得益于巨大的成长潜力,公司获得了包括高瓴、Orbimed等一众知名投资机构加持,尽管短期公司上市股价承压,不过长期而言这也意味着巨大的投资机会。而从市场催化因子来看,随着未来3款新上市或临近上市新药在市场上的潜力不断获得验证,公司将大概率迎来大级别的投资机会。</p></body></html>","source":"gelonghui_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>先声药业(02096.HK):行业长跑型选手,医药\"组合拳\"构建护城河</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n先声药业(02096.HK):行业长跑型选手,医药\"组合拳\"构建护城河\n</h2>\n\n<h4 class=\"meta\">\n\n\n2020-10-27 12:54 北京时间 <a href=http://www.gelonghui.com/p/420234><strong>格隆汇</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>今日先声药业(02096.HK)登陆港交所,截至发稿时为止股价表现不佳,在市场上引发了一定的争议,而在这之前,公司公开发售获得了589.47倍认购,在市场如此追捧的背景下,先声药业股价下跌究竟是何原因?又该如何看待这家公司的长期价值呢?初步分析来看,我们认为这与近期一系列公司密集在港股上市,尤其是蚂蚁集团上市消息对港股打新市场环境带来的影响有较大关系。此前市场曾一度传出蚂蚁集团上市暂缓,而彼时正值...</p>\n\n<a href=\"http://www.gelonghui.com/p/420234\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://img7.gelonghui.com/column/10.png","relate_stocks":{"159938":"医药","02096":"先声药业","09939":"开拓药业-B"},"source_url":"http://www.gelonghui.com/p/420234","is_english":false,"share_image_url":"https://static.laohu8.com/6b8fa6424aebe95f6781d04ef17a1852","article_id":"2078500372","content_text":"今日先声药业(02096.HK)登陆港交所,截至发稿时为止股价表现不佳,在市场上引发了一定的争议,而在这之前,公司公开发售获得了589.47倍认购,在市场如此追捧的背景下,先声药业股价下跌究竟是何原因?又该如何看待这家公司的长期价值呢?初步分析来看,我们认为这与近期一系列公司密集在港股上市,尤其是蚂蚁集团上市消息对港股打新市场环境带来的影响有较大关系。此前市场曾一度传出蚂蚁集团上市暂缓,而彼时正值先声药业的招股期,这在一定程度上刺激了先声药业的招股表现,而随着蚂蚁集团上市得到确认,可能引发的抽水效应预期之下,继而又给上市的新股带来了一定压力。在此背景下,先声药业未有预期表现也就不难理解。而此次先声药业获得了高瓴资本的加持,这也是进一步刺激投资者认购的重要因素,也难怪会有人因暗盘表现吐槽高瓴资本\"翻车\"。不过私以为,正如高瓴资本的创始人所践行的投资标准——做时间的朋友,仅为先声药业短期的价格波动而为之\"酸柠檬\",实在不可取,不妨具体来探讨为何在高领资本眼中先声药业是一家值得长期下注的企业。1、昔日国内首个美股上市药企,资本市场二聚首此次港股上市并非先声药业首次亮相资本市场,早在2007年,该公司曾成功登陆纽交所,并成为当时国内第一家在纽交所上市的化学生物药企。上市初期先声药业市值还一度刷新了亚洲化学生物药企的IPO记录,不过后来,由于公司长期在美股市场面临低估局面,公司最终选择在2013年完成私有化从纽交所退市。从当时退市的背景来看,彼时公司正处于黄金发展期,由于面临强研发投入在一定程度上影响了公司短期盈利,导致财务报表并不好看,而资本市场向来也多是对业绩唯马是瞻,投资者给出的估值不高,再融资难度较大,维持上市地位也将需要一定的成本支出,综合一系列因素考量下,私有化退市成为彼时先声药业面临的更为明智的选择。随着近年来港交所积极改革,医药企业面临的资本市场环境已经与当年的美股市场不可同日而语,其中最具看点的便是未盈利的B字头股票走出了大牛行情。除了资本市场的变化,先声药业经过多年的沉淀实际上也早已经脱胎换骨,公司连续多年位居“中国创新力医药企业十强”和“中国制药工业百强”,行业地位进一步提升,研发成果得到市场验证。在此背景下,二次上市再融资,寻求进一步做大做强成了可能。作为一家快速转型为创新和研发驱动的制药公司,先声药业目前主要专注三大领域,包括肿瘤疾病(包括细胞治疗领域)、中枢神经系统疾病、自身免疫疾病。根据弗若斯特沙利文的资料,按药品销售收入计,上述三大治疗领域2019年合计占中国药品市场的24.7%,且2015年到2019年的增长速度快于整体中国医药行业增速,预计这一趋势在未来几年将延续。由上不难看出公司在医药行业选择的赛道具有非常乐观的前景,那么对于公司本身而言,其机会和竞争力又体现在何处?2、左手\"现金牛\",右手\"冲天炮\"相较于B字尾未盈利的生物医药企业,先声药业与其最大的不同之处在于公司既有良好的现金牛业务能够在一定程度上支撑公司日常运营及强研发投入,同时又有具备想象空间的在研创新药产品,为未来的发展增添潜在动力源,可被视作将来能够带领公司业绩一飞冲天的\"冲天炮\"。从\"现金牛\"来看,目前公司共销售10款产品,其中7种仿制药、2种一类创新药及1种改良型新药,这些药品在相应的细分领域占有领先的市场地位,数据显示,10款主要产品的销售额占2019财年总收入的81.9%。其中占比最多的产品包括恩度、必存和艾得辛,三者2019财年销售额合计占比总收入超5成。另外按照此前提到的公司具体聚焦的肿瘤疾病、中枢神经系统疾病和自身免疫疾病三大领域来看,这三大领域的收入2019财年占比达到65.9%,可以说是公司的基本盘所在。结合财报来数据来看,先声药业营收、净利润近年来保持高增长态势,2017-2019营收年复合增长率达到近20%,净利润年复合增长率达到70%。此外体现在盈利指标方面,2017-2019年,先声药业的毛利率分别为84.8%、82.9%、82.4%;ROE分别为21.3%、43.9%、65.9%,毛利率持续维持高位姿态,盈利能力不断强化。可见公司所战略性布局的三大领域以及多元化的产品,得到了市场认可,保持了稳定的销售态势,并成为保障公司业绩稳健表现的重要根基。而基于此,相较于很多处于研发阶段但并未有正式产品上市的未盈利企业,先声医药具备了一定的经营安全垫,而这也将体现在投资上,增厚了投资者的安全边际。而再来看为未来赋予想象空间的在研药物方面,根据招股书,目前先声药业拥有近50个处于不同开发阶段的在研创新药产品,包括小分子药物、大分子药物和CART细胞治疗,其中近10种已取得新药临床批文或处于临床阶段,预计未来几年将就17种仿制药及生物类似药在研产品,提交或取得仿制药注册申请或进口药品注册申请。可以说其构筑了具有前瞻性且市场潜力巨大的系统研发管线。而以市场关注最多的新上市或临近上市的重磅产品为例,公司于今年8月份推出的恩瑞舒(阿巴西普注射液)以及先必新(依达拉奉右莰醇注射用浓溶液),均通过国家医保药品大病谈判资格审查,以获纳入国家医保药品目录。其中阿巴西普作为全球类风湿关节炎领域第一个也是唯一一个被批准的T细胞选择性共刺激免疫调节剂,恩瑞舒针对ACPA阳性患者疗效更强,安全性更好。2019年,阿巴西普全球销售额接近30亿美元,此次进入中国大陆市场后,将惠及国内600万类风关患者,市场前景十分可观。另外,国家1类新药先必新(依达拉奉右莰醇注射用浓溶液)其作为全球脑卒中治疗领域近5年来唯一获批上市销售的创新药,其可显著降低急性缺血性脑卒中(AIS)引发的脑神经损伤,并将现有治疗时间窗从24小时延长至48小时。而根据《中国脑卒中防治报告》,我国每12秒就有一人发生脑卒中,每21秒就有一人死于脑卒中,全国每年死于脑卒中的患者高达190多万。先必新的上市,为卒中患者带来新的选择,也有望进一步打开市场格局。最后再来看即将上市的重磅产品KN035 (Envafolimab),该产品尽管只是合作产品,先声药业主要负责该产品在中国大陆的独家商业推广,并以此收取推广服务费。不过作为全球首个上市的通过皮下注射给药的PD1/PD-L1抗体。KN035在安全性、便利性、依从性等方面和已上市的同类药物相比,具有显著的差异化优势,目前其已获得了美国FDA的晚期胆道癌孤儿药资格认定,市场前景也相当乐观。综上不难看出,先声药业不论是在自身的研发领域,还是优势互补合作方面都展现了实力雄厚的一面,透过多维度布局不仅拓宽了市场机会,同时也打开了更多向上发展空间。3、短期承压不改长期趋势,两大亮点支撑价值创造当前受短期市场环境影响,先声药业上市表现面临一定压力,不过随着巨无霸蚂蚁集团的落地,市场恢复常态,在蚂蚁金服的吸金效应之下,更多市场资金的涌入将有助于提升整体市场流动性,带动基本面优质的低估值企业迎来修复。而从长远视角而言,我们总结了两大亮点,认为将是公司投资价值的重要体现所在,也是支撑公司未来长期估值表现的核心要素。其一,前瞻性的市场眼光以及持续提升的研发能力不论是早在2015年就上市了国内首个肿瘤生物药物开创市场先河,还是今年两大重磅药品一经面试即入围医保审查名单,这些均有力体现了先声药业长期发展过程中积淀的超强市场洞察力。公司扎根医药行业中更具备前景和增长机会的三大领域,在优势赛道上抢跑,成长性也将得到更进一步的体现。此外研发上,过去公司业务主要以仿制药为主,而随着行业仿制药业务加速洗牌,公司大力推进创新药研发,在研发能力上有了长足的进步。招股资料显示,先声药业在江苏省南京市、上海市和美国波士顿拥有三个研发中心,为创新药物国家重点实验室。人员配备上,公司研发部门共有全职员工756人,其中331人拥有硕士学历,116人拥有博士学历。而在研发投入方面,其占营收比节节攀升,19年达到14.2%。其二,商业化水平领先,加速资源整合,优势互补下打开成长空间作为老牌药企,先声药业在行业内有着丰富的资源积累,商业化水平处于行业领先水准。数据显示,截止2020年6月30日,公司拥有超过2800名销售及营销人员,遍布中国31个省、市级自治区,覆盖全国约2100家三级医院,约17000家其他医院、医疗机构,以及超过200家大型全国性或区域性连锁药店。优质的资源网络及市场影响力为后续公司在研产品的上市推广带来了强劲支撑,而借助此公司还打开了新的业务窗口。此前上面提到的重磅产品KN035 (Envafolimab)即是先声药业凭借其强大的商业化能力,从而获得该药品国内独家商业推广,并借此取得推广收入。从长远来看,借助与优质资源的合作,在早期研发、临床开发、商业化推广上各方实现优势互补,这也将有助于进一步为公司创造新的业务价值点,在资源整合之中打开更大的市场机会。4、结语此前兴业证券观点指出,国内企业的研发类型从单纯的模仿/改进到快速跟进(Fast-follow)甚至逐步追求 First-in-class。研发管线逐步成为投资者估值和决定企业股价走势的重要考量因素。结合先声药业的发展路径来看,其不断加大研发投入,打造了多元化创新产品组合,这些布局不仅为未来的业绩增长带来了想象空间,同时也将有力支撑公司未来股价表现。也正是得益于巨大的成长潜力,公司获得了包括高瓴、Orbimed等一众知名投资机构加持,尽管短期公司上市股价承压,不过长期而言这也意味着巨大的投资机会。而从市场催化因子来看,随着未来3款新上市或临近上市新药在市场上的潜力不断获得验证,公司将大概率迎来大级别的投资机会。","news_type":1},"isVote":1,"tweetType":1,"viewCount":209,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":306334555,"gmtCreate":1604283608077,"gmtModify":1703832335914,"author":{"id":"3468821296231434","authorId":"3468821296231434","name":"JoshuaS","avatar":"https://static.tigerbbs.com/a71fb2b3a9de6819c3c7b1feac5d0ef2","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/06998\">$嘉和生物-B(06998)$</a>这个铁憨憨啊,天天就知道跌。","listText":"<a href=\"https://laohu8.com/S/06998\">$嘉和生物-B(06998)$</a>这个铁憨憨啊,天天就知道跌。","text":"$嘉和生物-B(06998)$这个铁憨憨啊,天天就知道跌。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/306334555","isVote":1,"tweetType":1,"viewCount":581,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":306921836,"gmtCreate":1604221608025,"gmtModify":1703832249372,"author":{"id":"3468821296231434","authorId":"3468821296231434","name":"JoshuaS","avatar":"https://static.tigerbbs.com/a71fb2b3a9de6819c3c7b1feac5d0ef2","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/06998\">$嘉和生物-B(06998)$</a>周一涨涨吧","listText":"<a href=\"https://laohu8.com/S/06998\">$嘉和生物-B(06998)$</a>周一涨涨吧","text":"$嘉和生物-B(06998)$周一涨涨吧","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/306921836","isVote":1,"tweetType":1,"viewCount":665,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":306079075,"gmtCreate":1604141949697,"gmtModify":1703832156094,"author":{"id":"3468821296231434","authorId":"3468821296231434","name":"JoshuaS","avatar":"https://static.tigerbbs.com/a71fb2b3a9de6819c3c7b1feac5d0ef2","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/06988\">$乐享互动(06988)$</a>竟然还在涨","listText":"<a href=\"https://laohu8.com/S/06988\">$乐享互动(06988)$</a>竟然还在涨","text":"$乐享互动(06988)$竟然还在涨","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/306079075","isVote":1,"tweetType":1,"viewCount":553,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":308410551,"gmtCreate":1604044893373,"gmtModify":1703831810695,"author":{"id":"3468821296231434","authorId":"3468821296231434","name":"JoshuaS","avatar":"https://static.tigerbbs.com/a71fb2b3a9de6819c3c7b1feac5d0ef2","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/06998\">$嘉和生物-B(06998)$</a>大哥,公司出啥事儿了","listText":"<a href=\"https://laohu8.com/S/06998\">$嘉和生物-B(06998)$</a>大哥,公司出啥事儿了","text":"$嘉和生物-B(06998)$大哥,公司出啥事儿了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/308410551","isVote":1,"tweetType":1,"viewCount":802,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":308877553,"gmtCreate":1603952707972,"gmtModify":1703831364029,"author":{"id":"3468821296231434","authorId":"3468821296231434","name":"JoshuaS","avatar":"https://static.tigerbbs.com/a71fb2b3a9de6819c3c7b1feac5d0ef2","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/06998\">$嘉和生物-B(06998)$</a>没量呀","listText":"<a href=\"https://laohu8.com/S/06998\">$嘉和生物-B(06998)$</a>没量呀","text":"$嘉和生物-B(06998)$没量呀","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/308877553","isVote":1,"tweetType":1,"viewCount":522,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":308300059,"gmtCreate":1603853933171,"gmtModify":1703830959523,"author":{"id":"3468821296231434","authorId":"3468821296231434","name":"JoshuaS","avatar":"https://static.tigerbbs.com/a71fb2b3a9de6819c3c7b1feac5d0ef2","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/06998\">$嘉和生物-B(06998)$</a>kao","listText":"<a href=\"https://laohu8.com/S/06998\">$嘉和生物-B(06998)$</a>kao","text":"$嘉和生物-B(06998)$kao","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/308300059","isVote":1,"tweetType":1,"viewCount":484,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":301771012,"gmtCreate":1603782238136,"gmtModify":1703830686994,"author":{"id":"3468821296231434","authorId":"3468821296231434","name":"JoshuaS","avatar":"https://static.tigerbbs.com/a71fb2b3a9de6819c3c7b1feac5d0ef2","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/06998\">$嘉和生物-B(06998)$</a>这是彻底没心跳了?","listText":"<a href=\"https://laohu8.com/S/06998\">$嘉和生物-B(06998)$</a>这是彻底没心跳了?","text":"$嘉和生物-B(06998)$这是彻底没心跳了?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/301771012","isVote":1,"tweetType":1,"viewCount":670,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":301563028,"gmtCreate":1603694632964,"gmtModify":1703830364445,"author":{"id":"3468821296231434","authorId":"3468821296231434","name":"JoshuaS","avatar":"https://static.tigerbbs.com/a71fb2b3a9de6819c3c7b1feac5d0ef2","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/06078\">$海吉亚医疗(06078)$</a>看好这支","listText":"<a href=\"https://laohu8.com/S/06078\">$海吉亚医疗(06078)$</a>看好这支","text":"$海吉亚医疗(06078)$看好这支","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/301563028","isVote":1,"tweetType":1,"viewCount":481,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":398038113,"gmtCreate":1606788512032,"gmtModify":1703844421830,"author":{"id":"3468821296231434","authorId":"3468821296231434","name":"JoshuaS","avatar":"https://static.tigerbbs.com/a71fb2b3a9de6819c3c7b1feac5d0ef2","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/06998\">$嘉和生物-B(06998)$</a>38个交易日里,25个收红下跌,剩下13个收绿的交易日里,6个横盘微动,真正实现3%以上涨幅的只有3个交易日,嘉和生物真是一支优秀的股票!","listText":"<a href=\"https://laohu8.com/S/06998\">$嘉和生物-B(06998)$</a>38个交易日里,25个收红下跌,剩下13个收绿的交易日里,6个横盘微动,真正实现3%以上涨幅的只有3个交易日,嘉和生物真是一支优秀的股票!","text":"$嘉和生物-B(06998)$38个交易日里,25个收红下跌,剩下13个收绿的交易日里,6个横盘微动,真正实现3%以上涨幅的只有3个交易日,嘉和生物真是一支优秀的股票!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":13,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/398038113","isVote":1,"tweetType":1,"viewCount":1351,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":975495731,"gmtCreate":1600782860623,"gmtModify":1703822461783,"author":{"id":"3468821296231434","authorId":"3468821296231434","name":"JoshuaS","avatar":"https://static.tigerbbs.com/a71fb2b3a9de6819c3c7b1feac5d0ef2","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/XPEV\">$小鹏汽车(XPEV)$</a>这走势也太恶心了吧","listText":"<a href=\"https://laohu8.com/S/XPEV\">$小鹏汽车(XPEV)$</a>这走势也太恶心了吧","text":"$小鹏汽车(XPEV)$这走势也太恶心了吧","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/975495731","isVote":1,"tweetType":1,"viewCount":1290,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":977281165,"gmtCreate":1601603245657,"gmtModify":1703824871221,"author":{"id":"3468821296231434","authorId":"3468821296231434","name":"JoshuaS","avatar":"https://static.tigerbbs.com/a71fb2b3a9de6819c3c7b1feac5d0ef2","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/01429\">$天任集团(01429)$</a>任性","listText":"<a href=\"https://laohu8.com/S/01429\">$天任集团(01429)$</a>任性","text":"$天任集团(01429)$任性","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":1,"link":"https://laohu8.com/post/977281165","isVote":1,"tweetType":1,"viewCount":636,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":974390350,"gmtCreate":1600926664970,"gmtModify":1703822997483,"author":{"id":"3468821296231434","authorId":"3468821296231434","name":"JoshuaS","avatar":"https://static.tigerbbs.com/a71fb2b3a9de6819c3c7b1feac5d0ef2","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/06988\">$乐享互动(06988)$</a>该说点什么好呢","listText":"<a href=\"https://laohu8.com/S/06988\">$乐享互动(06988)$</a>该说点什么好呢","text":"$乐享互动(06988)$该说点什么好呢","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/974390350","isVote":1,"tweetType":1,"viewCount":661,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3446671167569290","authorId":"3446671167569290","name":"gzSunny","avatar":"https://static.tigerbbs.com/7f5e13babe5f704aea3304b5581f7c0c","crmLevel":5,"crmLevelSwitch":0},"content":"还好走得早,亏手续费和利息","text":"还好走得早,亏手续费和利息","html":"还好走得早,亏手续费和利息"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":974831495,"gmtCreate":1600993355117,"gmtModify":1703823267657,"author":{"id":"3468821296231434","authorId":"3468821296231434","name":"JoshuaS","avatar":"https://static.tigerbbs.com/a71fb2b3a9de6819c3c7b1feac5d0ef2","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/XPEV\">$小鹏汽车(XPEV)$</a>唉,还好前两天分批跑了","listText":"<a href=\"https://laohu8.com/S/XPEV\">$小鹏汽车(XPEV)$</a>唉,还好前两天分批跑了","text":"$小鹏汽车(XPEV)$唉,还好前两天分批跑了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/974831495","isVote":1,"tweetType":1,"viewCount":97,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":975756210,"gmtCreate":1600849254430,"gmtModify":1703822680643,"author":{"id":"3468821296231434","authorId":"3468821296231434","name":"JoshuaS","avatar":"https://static.tigerbbs.com/a71fb2b3a9de6819c3c7b1feac5d0ef2","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/06988\">$乐享互动(06988)$</a>今开两块七,收盘两块七,玩空气呢?!","listText":"<a href=\"https://laohu8.com/S/06988\">$乐享互动(06988)$</a>今开两块七,收盘两块七,玩空气呢?!","text":"$乐享互动(06988)$今开两块七,收盘两块七,玩空气呢?!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/975756210","isVote":1,"tweetType":1,"viewCount":52,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":972301398,"gmtCreate":1600092570314,"gmtModify":1703820289910,"author":{"id":"3468821296231434","authorId":"3468821296231434","name":"JoshuaS","avatar":"https://static.tigerbbs.com/a71fb2b3a9de6819c3c7b1feac5d0ef2","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/XPEV\">$小鹏汽车(XPEV)$</a>上市12天,10天都是阴线,也是没谁了。新能源汽车就你表现最差了吧!","listText":"<a href=\"https://laohu8.com/S/XPEV\">$小鹏汽车(XPEV)$</a>上市12天,10天都是阴线,也是没谁了。新能源汽车就你表现最差了吧!","text":"$小鹏汽车(XPEV)$上市12天,10天都是阴线,也是没谁了。新能源汽车就你表现最差了吧!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/972301398","isVote":1,"tweetType":1,"viewCount":1086,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3527667803686145","authorId":"3527667803686145","name":"社区成长助手","avatar":"https://static.tigerbbs.com/2b7c7106b5c0c8b0037faa67439d898f","crmLevel":1,"crmLevelSwitch":0},"content":"终于等到了您的初发帖[比心][比心]希望您能在老虎社区玩得愉快、赚得开心!如果您想创作优质文章,请查看老虎社区创作指引","text":"终于等到了您的初发帖[比心][比心]希望您能在老虎社区玩得愉快、赚得开心!如果您想创作优质文章,请查看老虎社区创作指引","html":"终于等到了您的初发帖[比心][比心]希望您能在老虎社区玩得愉快、赚得开心!如果您想创作优质文章,请查看老虎社区创作指引"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":302371856,"gmtCreate":1604566064875,"gmtModify":1703833781393,"author":{"id":"3468821296231434","authorId":"3468821296231434","name":"JoshuaS","avatar":"https://static.tigerbbs.com/a71fb2b3a9de6819c3c7b1feac5d0ef2","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/06998\">$嘉和生物-B(06998)$</a>大哥,学学药明巨诺今天的涨幅吧","listText":"<a href=\"https://laohu8.com/S/06998\">$嘉和生物-B(06998)$</a>大哥,学学药明巨诺今天的涨幅吧","text":"$嘉和生物-B(06998)$大哥,学学药明巨诺今天的涨幅吧","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/302371856","isVote":1,"tweetType":1,"viewCount":797,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":308410551,"gmtCreate":1604044893373,"gmtModify":1703831810695,"author":{"id":"3468821296231434","authorId":"3468821296231434","name":"JoshuaS","avatar":"https://static.tigerbbs.com/a71fb2b3a9de6819c3c7b1feac5d0ef2","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/06998\">$嘉和生物-B(06998)$</a>大哥,公司出啥事儿了","listText":"<a href=\"https://laohu8.com/S/06998\">$嘉和生物-B(06998)$</a>大哥,公司出啥事儿了","text":"$嘉和生物-B(06998)$大哥,公司出啥事儿了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/308410551","isVote":1,"tweetType":1,"viewCount":802,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":309273056,"gmtCreate":1602715231275,"gmtModify":1703827586256,"author":{"id":"3468821296231434","authorId":"3468821296231434","name":"JoshuaS","avatar":"https://static.tigerbbs.com/a71fb2b3a9de6819c3c7b1feac5d0ef2","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/NIO\">$蔚来(NIO)$</a>牛逼!!!","listText":"<a href=\"https://laohu8.com/S/NIO\">$蔚来(NIO)$</a>牛逼!!!","text":"$蔚来(NIO)$牛逼!!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/309273056","isVote":1,"tweetType":1,"viewCount":298,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":974555812,"gmtCreate":1601259170836,"gmtModify":1703823740430,"author":{"id":"3468821296231434","authorId":"3468821296231434","name":"JoshuaS","avatar":"https://static.tigerbbs.com/a71fb2b3a9de6819c3c7b1feac5d0ef2","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/02101\">$福禄控股(02101)$</a>请问贵公司股票何时能出现一根绿色的日k线?!","listText":"<a href=\"https://laohu8.com/S/02101\">$福禄控股(02101)$</a>请问贵公司股票何时能出现一根绿色的日k线?!","text":"$福禄控股(02101)$请问贵公司股票何时能出现一根绿色的日k线?!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/974555812","isVote":1,"tweetType":1,"viewCount":699,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":972573439,"gmtCreate":1600299979221,"gmtModify":1703821080769,"author":{"id":"3468821296231434","authorId":"3468821296231434","name":"JoshuaS","avatar":"https://static.tigerbbs.com/a71fb2b3a9de6819c3c7b1feac5d0ef2","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/09633\">$农夫山泉(09633)$</a>真是水往低处走","listText":"<a href=\"https://laohu8.com/S/09633\">$农夫山泉(09633)$</a>真是水往低处走","text":"$农夫山泉(09633)$真是水往低处走","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/972573439","isVote":1,"tweetType":1,"viewCount":92,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":307977128,"gmtCreate":1605439594164,"gmtModify":1703837718730,"author":{"id":"3468821296231434","authorId":"3468821296231434","name":"JoshuaS","avatar":"https://static.tigerbbs.com/a71fb2b3a9de6819c3c7b1feac5d0ef2","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/06998\">$嘉和生物-B(06998)$</a>涨涨涨","listText":"<a href=\"https://laohu8.com/S/06998\">$嘉和生物-B(06998)$</a>涨涨涨","text":"$嘉和生物-B(06998)$涨涨涨","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/307977128","isVote":1,"tweetType":1,"viewCount":711,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":304673686,"gmtCreate":1605231586845,"gmtModify":1703836894188,"author":{"id":"3468821296231434","authorId":"3468821296231434","name":"JoshuaS","avatar":"https://static.tigerbbs.com/a71fb2b3a9de6819c3c7b1feac5d0ef2","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/06998\">$嘉和生物-B(06998)$</a>硬一次,软三天","listText":"<a href=\"https://laohu8.com/S/06998\">$嘉和生物-B(06998)$</a>硬一次,软三天","text":"$嘉和生物-B(06998)$硬一次,软三天","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/304673686","isVote":1,"tweetType":1,"viewCount":1011,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":301563028,"gmtCreate":1603694632964,"gmtModify":1703830364445,"author":{"id":"3468821296231434","authorId":"3468821296231434","name":"JoshuaS","avatar":"https://static.tigerbbs.com/a71fb2b3a9de6819c3c7b1feac5d0ef2","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/06078\">$海吉亚医疗(06078)$</a>看好这支","listText":"<a href=\"https://laohu8.com/S/06078\">$海吉亚医疗(06078)$</a>看好这支","text":"$海吉亚医疗(06078)$看好这支","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/301563028","isVote":1,"tweetType":1,"viewCount":481,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":301209238,"gmtCreate":1603501371624,"gmtModify":1703830162007,"author":{"id":"3468821296231434","authorId":"3468821296231434","name":"JoshuaS","avatar":"https://static.tigerbbs.com/a71fb2b3a9de6819c3c7b1feac5d0ef2","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/06998\">$嘉和生物-B(06998)$</a>大哥,差不多得了","listText":"<a href=\"https://laohu8.com/S/06998\">$嘉和生物-B(06998)$</a>大哥,差不多得了","text":"$嘉和生物-B(06998)$大哥,差不多得了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/301209238","isVote":1,"tweetType":1,"viewCount":278,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":303183995,"gmtCreate":1603017426017,"gmtModify":1703828476115,"author":{"id":"3468821296231434","authorId":"3468821296231434","name":"JoshuaS","avatar":"https://static.tigerbbs.com/a71fb2b3a9de6819c3c7b1feac5d0ef2","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/09988\">$阿里巴巴-SW(09988)$</a>竟然又涨了","listText":"<a href=\"https://laohu8.com/S/09988\">$阿里巴巴-SW(09988)$</a>竟然又涨了","text":"$阿里巴巴-SW(09988)$竟然又涨了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/303183995","isVote":1,"tweetType":1,"viewCount":258,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":300739135,"gmtCreate":1602402922527,"gmtModify":1703826549379,"author":{"id":"3468821296231434","authorId":"3468821296231434","name":"JoshuaS","avatar":"https://static.tigerbbs.com/a71fb2b3a9de6819c3c7b1feac5d0ef2","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/06998\">$嘉和生物-B(06998)$</a>冲啊嘉和,不能输给云顶","listText":"<a href=\"https://laohu8.com/S/06998\">$嘉和生物-B(06998)$</a>冲啊嘉和,不能输给云顶","text":"$嘉和生物-B(06998)$冲啊嘉和,不能输给云顶","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/300739135","isVote":1,"tweetType":1,"viewCount":362,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":977475990,"gmtCreate":1601783308410,"gmtModify":1703825199997,"author":{"id":"3468821296231434","authorId":"3468821296231434","name":"JoshuaS","avatar":"https://static.tigerbbs.com/a71fb2b3a9de6819c3c7b1feac5d0ef2","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/09988\">$阿里巴巴-SW(09988)$</a>长期看好","listText":"<a href=\"https://laohu8.com/S/09988\">$阿里巴巴-SW(09988)$</a>长期看好","text":"$阿里巴巴-SW(09988)$长期看好","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/977475990","isVote":1,"tweetType":1,"viewCount":218,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":974663769,"gmtCreate":1601041635251,"gmtModify":1703823440593,"author":{"id":"3468821296231434","authorId":"3468821296231434","name":"JoshuaS","avatar":"https://static.tigerbbs.com/a71fb2b3a9de6819c3c7b1feac5d0ef2","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/06988\">$乐享互动(06988)$</a>说好的财报呢?!","listText":"<a href=\"https://laohu8.com/S/06988\">$乐享互动(06988)$</a>说好的财报呢?!","text":"$乐享互动(06988)$说好的财报呢?!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/974663769","isVote":1,"tweetType":1,"viewCount":364,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}